Many seniors may be unaware of the landmark coverage shift starting on July 1, with limited advertising seen from the government or Eli Lilly and Novo.
A landmark coverage shift for obesity drugs under Medicare is set to begin on July 1, impacting many seniors. However, a significant number of beneficiaries may be unaware of this change due to limited advertising efforts from the government and major pharmaceutical companies…
Market Samachar is a news aggregator. This article was originally published by CNBC. Tap the button above to read the full story on their site.